Physician profile
Kendall E Carll
NPI 1063596997
$138,100.53
in general payments reported to CMS, 2019-2025
6 companies · $2,644 in 2025
The $2,644 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.83 · 2020: $36K · 2021: $7,790 · 2022: $21K · 2023: $30K · 2024: $42K · 2025: $2,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Royalty Or License: $11K · Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,500.00 |
| Royalty Or License | $11,302.68 |
| Food and Beverage | $146.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $75,000.00 | 2022-2024 | |
| Evolution Spine, LLC | $62,923.93 | 2020-2025 | Whistler Modular Screw System |
| Si-Bone, INC. | $106.19 | 2025 | |
| Boston Scientific Corporation | $29.69 | 2019-2020 | |
| Augmedics INC. | $25.35 | 2024 | Xvision |
| Biotronik Nro, INC. | $15.37 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$594,011.88 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendall Carll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.